Mike Halloran

Naga described dispense ahead of the cycle, T&I inflecting for X-ray and optical, all tied to semiconductor packaging.

Dan gave specifics: broad-based backlog, ~6-month turnover, no elongation in lead times, actually shorter than before.

Dan described normal gradual recovery from Q4 trough through first half, in line with expectations. Not a rebound but steady improvement.

Dan confirmed no fundamental change in backlog timing or delivery requests. High visibility to Q3, being prudent about Q4 given macro dynamics. Naga added they are not seeing demand pullback in current patterns.

CEO noted IPS returned to 3% organic growth with packaging, product assembly, and precision ag sustaining. Polymer processing and automotive stabilized but not meaningfully inflecting. CFO added growth is largely in Asia Pacific with European and North American demand not yet inflecting.

CEO detailed strong dispense momentum from AI computing demand, X-ray beginning to inflect driven by semiconductor yield requirements on complex chips, and acoustic emission coming off 2 strong years with decent growth planned. Overall ATS expected north of mid-single-digit long-term targets.

CFO said IPS and ATS margins are good jump-off points, but MFS at 40% was a notable achievement not sustainable as a baseline, upper 30s is the right level. CEO added to think of roughly 100bps margin improvement from the divestiture.

CEO confirmed semiconductor strength still concentrated in AI and cloud computing, with automotive stabilizing and general electronics decent but at lower growth rates. Reiterated 50% of ATS from semiconductor, 15% automotive, remainder electronics.

CEO said M&A pipeline is healthy with no change in posture, but the company will remain strategically and financially disciplined. The buyback reflects balanced capital allocation, not a shift away from M&A.

CFO saw no direct customer evidence of pull-forward demand, with broad-based demand across electronics dispense and optical products. CEO added new products, customer supply chain redesign, and operational agility as key differentiators.

CFO sized the divestiture at ~4% of MFS sales and ~100bps accretive to segment margins post-sale, with no other active divestiture actions but ongoing annual portfolio assessment.

CEO gave detailed segment-by-segment color: ATS strong momentum from AI/semiconductor spending, MFS destocking reducing with Atrion above model, IPS ARAG strong but automotive remains headwind.

CFO reiterated 35% blended incremental margin target, with organic above and inorganic below that level.

CFO provided detailed segment color: low end assumes low single-digit ATS growth, flat-to-down IPS/MFS; high end assumes stronger ATS ramp and medical recovery.

Management confirmed Q4 ATS growth was normal, not anomalous, with positive order trends supporting modest continued growth.

Management provided detailed segment-by-segment end market outlook and confirmed guidance assumes normal seasonality with flat organic growth.

Pine tied the takedown entirely to the electric meter deployment slowdown from affordability and election-related caution. Water offsets: funnel up about 30%, double-digit water orders in Q1 and Q2.

Grogan walked the revenue progression quarter by quarter and said segments finish with positive book-to-bill and backlog build into 2027, with China comps and 80/20 walkaway largely behind them.

Continued buying in April, reassessing at month end. Managing leverage between 0.5-1.0x net debt/EBITDA. Balancing stock dislocation opportunities. Healthy balance sheet supports continued deployment across full framework.

Tracking $1B annual M&A deployment for mid-teens EPS growth. Bottom-up process with segment presidents owning targets yielding strong pipeline across all segments. German analytics acquisition ($219M) strengthens optical sensing and process applications. Expect significant revenue synergies through customer base leverage.

Structural engineering/technology changes to lift energy margin. Legacy projects in backlog still pressuring through 2026. MCS margins down slightly Q1, then sequential build. Robust margins by Q4 exit with water balance normalizing and energy improvements taking hold.

Q4 orders down ~70%, sales down ~30%. Headcount reduced 40%+. Local competition intense due to overcapacity. Applying 80/20 lens to focus on profitable opportunities with tech differentiation. No material improvement expected next 1-2 years but long-term growth expected at higher margins.

MCS down 1-2 points vs external expectations in Q1. WSS flattish. Water Infrastructure and Applied Water a little below full-year guide due to China first-half pressure.

Lower backlog from MCS normalization, China weakness in treatment, and walkaway revenue impacting orders before revenue. MCS had larger projects push from Q4 into H1 2026 putting pressure on Q1-Q2. Healthy commercial funnels for MCS and WSS give confidence in back-half progression.

Fundamental dynamics strong for all 4 segments. China headwind and slightly higher 80/20 walkaway (~1%+ next year) are the offsets. Resilient muni demand and differentiated tech on industrial side. Macro volatility remains but fundamentals solid.

Staying the course but rightsizing. ~40% workforce reduction in China. Sizing business for current demand and 2026. Like market long term. Teams reallocating resources to highest opportunity areas with matching technology.

Demand resilient across the board. WI down 2% but book-to-bill >1 against tough comps. UK and Canada funding delays expected to resolve in H2. MCS back to book-to-bill positive by year-end.

Tracking ahead of timeline. 80% of business has some stage of 80/20 implementation. Dewatering business began in Q2. All 4 segments now actively engaged. Applied Water and WI margin improvements are proof points.

Two-thirds price increase, one-third surcharge. Actions taken in Q1 and early Q2. Parts of backlog being repriced. Impact more back-half loaded.

No fundamental change. Looking to accelerate 80/20 in tariff-challenged areas. Restructuring on track, Q1 slightly ahead of schedule.

Detailed explanation of mix headwind, energy meters growing ~40% on refresh cycle, water meters low single digits. Full year margins will expand.

Shafer addressed both channels, describing retail share gains across the industry and the targeted actions to win back wholesale share, without quantifying share.

Anderson declined to discuss future price increases as too early; Lauber covered acceptance and timing but no quantified multi-quarter price-cost path was given.

CFO provided detailed quarterly cadence: China Q2 down ~15% from Q1 at 35-40% decrementals; some pricing pull-forward helping Q2 North America; Q2 EPS ~25% of full-year midpoint; back half stronger on boilers and China Q4 seasonality.

CEO acknowledged some pull-ahead is typical but emphasized close customer management and commitment to keeping customers competitive amid uncertainty.

Guided to more normalized 50-50 or 51-49 first/second half split versus 53-47 in prior years, with tough front-half comps, steel costs up 10%, carryover tariffs, and China subsidy lapping.

Management acknowledged accelerating competitive dynamics in wholesale over the past six months but emphasized their meaningful share in both channels and ability to navigate.

Chuck noted AOS targets margin-plus-cost coverage with price increases but acknowledged price fade over time. Some Q4 margin pressure expected. Deferred full answer to next quarter.

Chuck confirmed proactive replacement remains above 30% based on quarterly surveys. Something to watch but no trend change yet.

Steve framed it as broadening the aperture of options rather than a specific trigger. Still early stage with no decisions made. Did not specify timeline.

Chuck provided detailed cadence: China subsidy inconsistency pressures H2; NA will see steel +15-20% and full tariff impact in H2 offset by May pricing. Front half NA margins stronger than back half.

Kevin outlined short-term supplier adjustments and longer-term requalification options. Cross-functional task forces are managing the fluid situation, adapting plans as tariff policy evolves.

Chuck confirmed normalized 51/49 front/back half cadence. Kevin added channel inventories are flat to slightly down vs last year, better starting position than Q1 2024.

Chuck provided detailed quarterly cadence expectations with specific percentages and comp dynamics, noting 2025 returns to normal seasonality.

Kevin explained tankless headwind is ~50bp through 2025 during Nanjing-to-Juarez transition. Steve described water treatment repositioning toward dealer/wholesale channels.

Quantified the visibility improvement and tied it to the CapEx increase, naming the specific data center order positioned for 2027.

Answered directly, distinguishing longer lead-time OEM backlog build early in the quarter from distribution-channel order flow returning late in Q2 and into July.

CEO confirmed guidance raise tied to internal growth initiatives and investments including M&A rather than any real change in cyclical dynamics. Short and direct affirmation.

CEO confirmed cadence improvement across four months. Resilience in face of geopolitical headlines is testament to market strength. Diagnostic businesses not all moving in same direction, which is the missing piece for declaring full inflection. Modeled appropriately conservatively as flattish. Better than original assumptions but reasonably guarded.

CEO explained two Q1 seasonal dynamics: traditional FMT weather impact on water and agriculture, plus newer HST effect from larger orders with year-end fiscal budget profiles. HST orders captured late in Q4 have lead times pushing revenue into Q2. Expect typical V-shaped pattern.

CEO said FY2025 life science growth was low single-digit, driven by pharma applications offset by academic research pressure. Q4 government shutdown added uncertainty. Looking for NIH funding clarity as key inflection signal. Innovation pipeline strong with healthy platform release clip.

CEO said two things needed: base industrial entitlement volume inflection (overdue) and continued momentum in growth platforms. Water municipal-facing side was high single-digit grower this quarter. Mott continuing same integration work.

CEO explained historical growth tracked ISM one-for-one at lower side of low single digits. Phase III work moving fulcrum right through higher-tech assets aligned with 21st century secular trends. Target mid-single-digit growth through portfolio composition and integrated platform source code.

CEO explained current focus is tuck-ins and technology fillers to complement existing platforms. MSS built aggressively over last few years, now completing with complementary businesses like Micro-LAM. Mott being used as toolbox for HST broadly.

CEO confirmed characterization. Said confidence improved given patterns resolved in July. Everybody can see patterns working, can draw a straighter line than coming into the quarter. Customers, distributors, and end users confirming stability.

CEO emphasized 80/20 positioning in advantaged markets, cumulative $80M savings, low price points on critical solutions. Franchises hold up better to shocks given nature of solutions.

CFO walked through quarterly cadence: Q2 backlog supports 0-2% organic, H2 HST ramps $10M per quarter from Mott/pharma/space. Two-thirds of H2 earnings ramp from controllable actions.

CFO provided detailed sequential bridge: $40M projects, $0.22 impact, $0.20 share-based comp headwind. CEO added HST blanket orders have specific customer launch rates phased across 2025.

CEO explained combining businesses thematically enables commercial and back-office efficiencies, driving both top-line growth and earnings expansion by working both sides of the ratio.

Vicente gave a detailed region-by-region breakdown (Americas strongest, EMEA timing-driven weakness, China volumes strong) and end-market color.

Vicente confirmed Q1 came in as expected or better excluding Middle East. Low single-digit organic growth expected Q2-Q4 supported by backlog growth, short-cycle momentum, commercial investments, and moderating prior year comps.

Vicente noted U.S. compressor activity stabilized, core tools growing mid-single digits, PST short-cycle book-and-ship growing organically. Long-cycle funnel stable but elongated decision-making persists. Middle East delays contained to that region with 1/3 already recovered in April.

Vicente confirmed headwinds from renewable natural gas, electric vehicle, and photovoltaic comps are behind. China team delivering three consecutive quarters of positive organic growth through innovation and new solutions, not market recovery.

Vicente provided detailed end-market commentary: life sciences progressing with mid-teens Q4 orders, pharma/biopharma production strong both US and globally, medical device funnel active in China. General industrial more stable post peak tariff uncertainty. U.S. PMI above 50 in January for first time in 38 months but too early to call inflection.

Vicente noted Q3 positive across all regions except vacuum/blower in Europe (timing). PST accelerating, ITS improving sequentially. Secular trends in wastewater, life sciences, medical devices helping offset slower core industrial recovery. MQLs and long-cycle funnel moving in right direction with no cancellations.

Vicente noted ITS already at ~29% EBITDA margin near 2027 target. PST at ~31% with continued sequential improvement toward mid-30s target. Gross margins flat to slightly up. SG&A investments in commercial initiatives partially offsetting. 2026 H1 margin expansion muted from tariff comps.

Vik cited seasonality, volume flow-through, productivity initiatives (I2V), ongoing bolt-on integration, and easier Q4 PST comp as drivers of H2 margin expansion.

Vicente noted consistent momentum through Q2 and into July with no discernible declines. Highlighted long-cycle orders in IT&S building backlog for 2026 revenue. P&ST organic orders positive excluding hydrogen comp.

Vicente confirmed the volume contingency is precautionary. Explained tariff pricing +2% and FX/M&A +2% offset by -4% volume plug to keep total revenue guide intact.

Vicente noted good balance between short and long cycle. MQLs up double-digit, no cancellations in long-cycle funnel. Vik confirmed PST organic growth in both Precision Tech and Life Sciences.

Vik attributed weakness to ILC Dover A&D volume deleverage and China organic declines. Expects return to 30% EBITDA margin through 2025.

Vicente provided detailed H1/H2 split, regional growth assumptions, and confirmed guidance assumes stability rather than end market improvement.

CFO gave quarter-level margin guidance and said Q4 will be north of 50 basis points, largely led by PQI where fixed cost absorption and production line moves weighed.

CEO cited three drivers for the PQI ramp plus better exit funnels, stronger service growth, and new product launches funded by increased investment at spin.

CFO confirmed steady demand assumptions with no acceleration needed. CPG and food/beverage nondiscretionary. Municipal water steady in OpEx cycle. Sequential core growth improvement partly from easier H2 comps including Q4 3-day benefit.

CFO confirmed broad-based cost optimization across both segments and corporate with a slight bias toward PQI.

CFO clarified Q2 pricing impact was roughly one month. Structural price increases (not backlog repricing) with full run-rate impact in Q3-Q4. Water Quality pricing flowing faster than PQI due to contractual differences.

CFO provided clear cadence: Q3 margins similar to Q2 with modest improvement, Q4 meaningfully better as full pricing run-rate flows through and tariff mitigation completes.

CFO explained three factors driving Q1-to-Q2 step-down: tariff timing lag vs countermeasures, higher equipment mix continuing, and mathematical impact of protecting OP dollars. Feels good about core growth of low-to-mid single digits.

CFO clarified extra days offset in Q4 with no impact to Q2 or Q3 on year-over-year basis. Noted core growth above 5% even pro forma for extra days.

CFO confirmed guide assumes continuation of current trends with no significant seasonality. Both segments expected to deliver consistent low-to-mid single-digit growth.

CEO outlined continuation of positive trends: industrial water strength, CPG recovery with 6 quarters of recurring growth, and 3 quarters of equipment growth. Constructive outlook.